Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Titel:
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Auteur:
DeJesus, Edwin Ramgopal, Moti Crofoot, Gordon Ruane, Peter LaMarca, Anthony Mills, Anthony Martorell, Claudia T de Wet, Joseph Stellbrink, Hans-Jürgen Molina, Jean-Michel Post, Frank A Valero, Ignacio Pérez Porter, Danielle Liu, YaPei Cheng, Andrew Quirk, Erin SenGupta, Devi Cao, Huyen